celecoxib
The following drugs will decrease celecoxib effect
| # | enzyme | inducers |
| 0 | 2C9 | carbamazepine |
| 1 | 2C19 | carbamazepine |
| 2 | 2C9 | dabrafenib |
| 3 | 2C9 | enzalutamide |
| 4 | 2C19 | efavirenz |
| 5 | 2C19 | enzalutamide |
| 6 | 2C19 | letermovir |
| 7 | 2C9 | letermovir |
| 8 | 2C19 | norethindrone |
| 9 | 2C19 | prednisone |
| 10 | 2C9 | nevirapine |
| 11 | 2C9 | phenobarbital |
| 12 | 2C19 | rifampicin |
| 13 | 2C19 | ritonavir |
| 14 | 2C9 | rifampin |
| 15 | 2C9 | secobarbital |
the follwing drugs will
Increase celecoxib effect
| # | enzyme | Inhibitors | level |
| 0 | 2C9 | amiodarone | Moderate inhibitor |
| 1 | 2C19 | armodafinil | Weak inhibitor |
| 2 | 2C9 | capecitabine | Weak inhibitor |
| 3 | 2C9 | ceritinib | Weak inhibitor |
| 4 | 2C19 | chloramphenicol | In-Vitro Only |
| 5 | 2C19 | cimetidine | Weak inhibitor |
| 6 | 2C19 | citalopram | Weak inhibitor |
| 7 | 2C9 | efavirenz | Weak inhibitor |
| 8 | 2C19 | esomeprazole | Weak inhibitor |
| 9 | 2C19 | felbamate | Weak inhibitor |
| 10 | 2C9 | fenofibrate | In-Vitro Only |
| 11 | 2C9 | fluconazole | Moderate inhibitor |
| 12 | 2C19 | fluconazole | Moderate inhibitor |
| 13 | 2C19 | fluoxetine | Moderate inhibitor |
| 14 | 2C9 | fluvastatin | In-Vitro Only |
| 15 | 2C9 | fluvoxamine | In-Vitro Only |
| 16 | 2C19 | fluvoxamine | Strong inhibitor |
| 17 | 2C9 | isoniazid | Weak inhibitor |
| 18 | 2C19 | isoniazid | Weak inhibitor |
| 19 | 2C19 | ketoconazole | Moderate inhibitor |
| 20 | 2C19 | luliconazole | Weak inhibitor |
| 21 | 2C9 | metronidazole | Moderate inhibitor |
| 22 | 2C19 | modafinil | Weak inhibitor |
| 23 | 2C19 | omeprazole | Weak inhibitor |
| 24 | 2C19 | oral contraceptives | Weak inhibitor |
| 25 | 2C19 | oritavancin | In-Vitro Only |
| 26 | 2C19 | pantoprazole | Weak inhibitor |
| 27 | 2C9 | phenylbutazone | Moderate inhibitor |
| 28 | 2C9 | quercetin | Weak inhibitor |
| 29 | 2C19 | quercetin | In-Vitro Only |
| 30 | 2C9 | sulfamethoxazole | Weak inhibitor |
| 31 | 2C9 | sulfaphenazole | Strong inhibitor |
| 32 | 2C19 | ticlopidine | Strong inhibitor |
| 33 | 2C19 | topiramate | under review |
| 34 | 2C9 | voriconazole | Weak inhibitor |
| 35 | 2C19 | voriconazole | Moderate inhibitor |
| 36 | 2C9 | zafirlukast | Weak inhibitor |
The follwing drugs will Increase effect by celecoxib effect
| # | enzyme | drug | level |
| 1 | 2D6 | alprenolol | Weak inhibitor |
| 2 | 2D6 | amitriptyline | Weak inhibitor |
| 3 | 2D6 | amphetamine | Weak inhibitor |
| 4 | 2D6 | atomoxetine | Weak inhibitor |
| 5 | 2D6 | brexpiprazole | Weak inhibitor |
| 6 | 2D6 | bufuralol | Weak inhibitor |
| 7 | 2D6 | cariprazine | Weak inhibitor |
| 8 | 2D6 | carvedilol | Weak inhibitor |
| 9 | 2D6 | chlorpheniramine | Weak inhibitor |
| 10 | 2D6 | chlorpromazine | Weak inhibitor |
| 11 | 2D6 | citalopram | Weak inhibitor |
| 12 | 2D6 | clomipramine | Weak inhibitor |
| 13 | 2D6 | clonidine | Weak inhibitor |
| 14 | 2D6 | codeine | Weak inhibitor |
| 15 | 2D6 | debrisoquine | Weak inhibitor |
| 16 | 2D6 | desipramine | Weak inhibitor |
| 17 | 2D6 | deutetrabenazine | Weak inhibitor |
| 18 | 2D6 | dexfenfluramine | Weak inhibitor |
| 19 | 2D6 | dextromethorphan | Weak inhibitor |
| 20 | 2D6 | donepezil | Weak inhibitor |
| 21 | 2D6 | doxepin | Weak inhibitor |
| 22 | 2D6 | eliglustat | Weak inhibitor |
| 23 | 2D6 | encainide | Weak inhibitor |
| 24 | 2D6 | escitalopram | Weak inhibitor |
| 25 | 2D6 | flecainide | Weak inhibitor |
| 26 | 2D6 | fluoxetine | Weak inhibitor |
| 27 | 2D6 | fluvoxamine | Weak inhibitor |
| 28 | 2D6 | ibrutinib | Weak inhibitor |
| 29 | 2D6 | imipramine | Weak inhibitor |
| 30 | 2D6 | lidocaine | Weak inhibitor |
| 31 | 2D6 | metoclopramide | Weak inhibitor |
| 32 | 2D6 | metoprolol | Weak inhibitor |
| 33 | 2D6 | mexiletine | Weak inhibitor |
| 34 | 2D6 | minaprine | Weak inhibitor |
| 35 | 2D6 | nebivolol | Weak inhibitor |
| 36 | 2D6 | nortriptyline | Weak inhibitor |
| 37 | 2D6 | ondansetron | Weak inhibitor |
| 38 | 2D6 | oxycodone | Weak inhibitor |
| 39 | 2D6 | paroxetine | Weak inhibitor |
| 40 | 2D6 | perhexiline | Weak inhibitor |
| 41 | 2D6 | perphenazine | Weak inhibitor |
| 42 | 2D6 | phenacetin | Weak inhibitor |
| 43 | 2D6 | pimavanserin | Weak inhibitor |
| 44 | 2D6 | ponatinib | Weak inhibitor |
| 45 | 2D6 | promethazine | Weak inhibitor |
| 46 | 2D6 | propafenone | Weak inhibitor |
| 47 | 2D6 | propranolol | Weak inhibitor |
| 48 | 2D6 | risperidone | Weak inhibitor |
| 49 | 2D6 | rucaparib | Weak inhibitor |
| 50 | 2D6 | sparteine | Weak inhibitor |
| 51 | 2D6 | tamoxifen | Weak inhibitor |
| 52 | 2D6 | tetrabenzine | Weak inhibitor |
| 53 | 2D6 | thioridazine | Weak inhibitor |
| 54 | 2D6 | timolol | Weak inhibitor |
| 55 | 2D6 | tramadol | Weak inhibitor |
| 56 | 2D6 | umeclidinium | Weak inhibitor |
| 57 | 2D6 | valbenazine | Weak inhibitor |
| 58 | 2D6 | venlafaxine | Weak inhibitor |
| 59 | 2D6 | vilazodone | Weak inhibitor |
| 60 | 2D6 | zuclopenthixol | Weak inhibitor |
will
decrease celecoxib effect
celecoxib will not affect
Strong inhibitor is one that causes a ≥ 5-fold decrease in the plasma AUC values or more than 80% decrease in clearance.
Moderate inhibitor is one that causes a 2 fold to < 5-fold decrease in the plasma AUC values or 50-80% decrease in clearance.
Weak inhibitor is one that causes a ≥ 1.25-fold but < 2-fold decrease in the plasma AUC values or 20-50% decrease in clearance.
In-Vitro Only In-Vitro Only Inhibitor strength.
under review Inhibitor strength level is under review.